Major Surgical or Invasive Procedure: [**2125-1-21**]: Successful ultrasound-guided percutaneous cholecystostomy tube placement with drainage of dark bilious material.
History of Present Illness: 71 year old male with idiopathic pulmonary fibrosis with a known common bile duct stricture unknown etiology if bengin vs malignant.
He was planned for common bile duct exploration and possible resection on [**2125-1-31**] for suspcision of cancer either cholangiocarcinoma vs gallbladder cancer.
Past Medical History: PMHx: Idioathic pulmonary fibrosis, recent Kidney stones, asthma in childhood.
PSHx: ERCP with stent placement [**2124-12-6**], ERCP with cholangioscopy and stent placement [**2125-1-16**].
Family History: Non-contributory  Physical Exam: On Admission: Vital Signs: T 99.0 HR 82  BP 127/80 RR 14 O2 Sat 97% Non-rebreather General: No acute distress CV: Regular rate and rhythm Lungs: crackles bilaterally Abd: soft, distendend, tender in the right upper quadrant, guarding in the right upper quadrant Rectal: guaiac neg   Pertinent Results: On Admission:  [**2125-1-20**] 08:45PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.045* [**2125-1-20**] 08:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-25 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-1 PH-6.5 LEUK-NEG [**2125-1-20**] 08:45PM URINE  RBC-0 WBC-0 BACTERIA-RARE YEAST-NONE EPI-0 [**2125-1-20**] 05:50PM   LACTATE-1.7 [**2125-1-20**] 05:44PM   GLUCOSE-135* UREA N-14 CREAT-1.0 SODIUM-137 POTASSIUM-4.6 CHLORIDE-105 TOTAL CO2-24 ANION GAP-13 [**2125-1-20**] 05:44PM   ALT(SGPT)-32 AST(SGOT)-27 ALK PHOS-91 AMYLASE-90 TOT BILI-0.8 [**2125-1-20**] 05:44PM   LIPASE-108* [**2125-1-20**] 05:44PM   WBC-17.8*# RBC-4.08* HGB-12.0* HCT-35.6* MCV-87 MCH-29.3 MCHC-33.6 RDW-14.0 [**2125-1-20**] 05:44PM   NEUTS-89.9* LYMPHS-6.4* MONOS-3.3 EOS-0.1 BASOS-0.3 [**2125-1-20**] 05:44PM   PLT COUNT-244 [**2125-1-20**] 05:44PM   PT-14.0* PTT-26.4 INR(PT)-1.2* .
Decreased intrahepatic biliary ductal dilatation status post bile duct stent placement.
Evaluation for a snographic [**Doctor Last Name 515**] sign was limited as the patient had received pain medication prior to this study.
[**2125-1-24**] Chest CT: Since the prior chest CT in [**11-20**], there is marked worsening of extensive, geographic ground glass opacities bilaterally, but worse on the left.
[**2125-1-20**] Urine Cx: Negative.
Upon admission, he was made NPO, started on IV fluids, started on empiric IV Unasyn, a foley catheter was placed, and he was given IV Dilaudid PRN for pain with good effect.
Later that day, he underwent ultrasound-guided percutaneous cholecystostomy tube placement with drainage of 145 cc of dark bilious material, which was successful.
The patient was heplocked, and the foley catheter discontinued.
At this point, the plan of care was to discharge him home and have him return in 1 week for cholecystectomy and possible Roux-En-Y.
It was found that his (R)UQ abdominal process was compromising his respiratory function, and despite qualify surgery as high risk, it was felt there was not a non-surgical alternative.
By [**2125-1-25**], the patient required [**5-17**] litwers by nasal prong and Face mask at 50% to maintain his saturations.
Dr. [**Last Name (STitle) 2168**] (Pulmonary) had communicated ealier to Dr. [**Last Name (STitle) **] (Surgery) that the patient had experienced a flare of the IPF and that surgery would no longer be an option.
Mr. [**Known lastname 32955**] [**Last Name (Titles) 32956**] and with full understanding of his situation expressed his desire to change his code status to DNR/DNI, and to be returned home with hospice care to spend his final days with his extended family.
The patient and family were given support and comfort by the [**Hospital Ward Name 121**] 9 staff.
He was discharged home with appropriate pain and anxiolytic medications as well as home oxygen equipment.
The patient and family received discharge teaching with understanding verbalized and were in agreement with the discharge plan.
Ipratropium-Albuterol (Combivent) 18-103 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever or pain.
Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Allopurinol 300 mg Tablet Sig: One (1) Tablet PO once a day.
6. centrum Silver MVI 1 tablet PO daily 7.
Continuous Home Oxygen 2.5L via nasal cannula.
Ipratropium-Albuterol 18-103 mcg/Actuation Aerosol Sig: [**1-13**] Puffs Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever or pain.
Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Morphine Concentrate 20 mg/mL Solution Sig: 5-20 mg PO Q1-2HOUR:PRN as needed for pain: Give SL.
Ativan 1 mg Tablet Sig: One (1) Tablet PO every 4-6 hours as needed for anxiety: Patient in Hospice Care.
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 14 days.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed for shortness of breath or wheezing.
DNR/DNI   Discharge Condition: Mental Status:Clear and coherent Level of Consciousness:Alert and interactive Activity Status:Ambulatory - Independent   Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
Percutaneous Cholecystotomy Tube Care: *PTC capped.
*Wash the area gently with warm, soapy water or 1/2 strength hydrogen peroxide followed by saline rinse, pat dry, and place a drain sponge.
* [**Name8 (MD) **] MD [**First Name (Titles) **] [**Last Name (Titles) 269**] Nurse if experiencing fever, abdominal pain, nausea, vomiting for further instruction.
